1
|
Lambrecht S, Liu D, Dzaye O, Kamson DO, Reis J, Liebig T, Holdhoff M, Van Zijl P, Qin Q, Lin DDM. Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion. Brain Sci 2024; 14:126. [PMID: 38391701 PMCID: PMC10886779 DOI: 10.3390/brainsci14020126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2023] [Revised: 01/19/2024] [Accepted: 01/20/2024] [Indexed: 02/24/2024] Open
Abstract
MR perfusion imaging is important in the clinical evaluation of primary brain tumors, particularly in differentiating between true progression and treatment-induced change. The utility of velocity-selective ASL (VSASL) compared to the more commonly utilized DSC perfusion technique was assessed in routine clinical surveillance MR exams of 28 patients with high-grade gliomas at 1.5T. Using RANO criteria, patients were assigned to two groups, one with detectable residual/recurrent tumor ("RT", n = 9), and the other with no detectable residual/recurrent tumor ("NRT", n = 19). An ROI was drawn to encompass the largest dimension of the lesion with measures normalized against normal gray matter to yield rCBF and tSNR from VSASL, as well as rCBF and leakage-corrected relative CBV (lc-rCBV) from DSC. VSASL (rCBF and tSNR) and DSC (rCBF and lc-rCBV) metrics were significantly higher in the RT group than the NRT group allowing adequate discrimination (p < 0.05, Mann-Whitney test). Lin's concordance analyses showed moderate to excellent concordance between the two methods, with a stronger, moderate correlation between VSASL rCBF and DSC lc-rCBV (r = 0.57, p = 0.002; Pearson's correlation). These results suggest that VSASL is clinically feasible at 1.5T and has the potential to offer a noninvasive alternative to DSC perfusion in monitoring high-grade gliomas following therapy.
Collapse
Affiliation(s)
- Sebastian Lambrecht
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- Institute of Neuroradiology, University Hospital LMU Munich, 81377 Munich, Germany
| | - Dapeng Liu
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD 21205, USA
| | - Omar Dzaye
- Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - David O Kamson
- Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Jonas Reis
- Institute of Neuroradiology, University Hospital LMU Munich, 81377 Munich, Germany
| | - Thomas Liebig
- Institute of Neuroradiology, University Hospital LMU Munich, 81377 Munich, Germany
| | - Matthias Holdhoff
- Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| | - Peter Van Zijl
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD 21205, USA
| | - Qin Qin
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
- F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD 21205, USA
| | - Doris D M Lin
- Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
| |
Collapse
|
3
|
Bhargava P, Kim S, Reyes AA, Grenningloh R, Boschert U, Absinta M, Pardo C, Van Zijl P, Zhang J, Calabresi PA. Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition. Brain 2021; 144:1396-1408. [PMID: 33724342 DOI: 10.1093/brain/awab045] [Citation(s) in RCA: 40] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 11/17/2020] [Accepted: 12/03/2020] [Indexed: 02/06/2023] Open
Abstract
Leptomeningeal inflammation in multiple sclerosis is associated with worse clinical outcomes and greater cortical pathology. Despite progress in identifying this process in multiple sclerosis patients using post-contrast fluid-attenuated inversion recovery imaging, early trials attempting to target meningeal inflammation have been unsuccessful. There is a lack of appropriate model systems to screen potential therapeutic agents targeting meningeal inflammation. We utilized ultra-high field (11.7 T) MRI to perform post-contrast imaging in SJL/J mice with experimental autoimmune encephalomyelitis induced via immunization with proteolipid protein peptide (PLP139-151) and complete Freund's adjuvant. Imaging was performed in both a cross-sectional and longitudinal fashion at time points ranging from 2 to 14 weeks post-immunization. Following imaging, we euthanized animals and collected tissue for pathological evaluation, which revealed dense cellular infiltrates corresponding to areas of contrast enhancement involving the leptomeninges. These areas of meningeal inflammation contained B cells (B220+), T cells (CD3+) and myeloid cells (Mac2+). We also noted features consistent with tertiary lymphoid tissue within these areas, namely the presence of peripheral node addressin-positive structures, C-X-C motif chemokine ligand-13 (CXCL13)-producing cells and FDC-M1+ follicular dendritic cells. In the cortex adjacent to areas of meningeal inflammation we identified astrocytosis, microgliosis, demyelination and evidence of axonal stress/damage. Since areas of meningeal contrast enhancement persisted over several weeks in longitudinal experiments, we utilized this model to test the effects of a therapeutic intervention on established meningeal inflammation. We randomized mice with evidence of meningeal contrast enhancement on MRI scans performed at 6 weeks post-immunization, to treatment with either vehicle or evobrutinib [a Bruton tyrosine kinase (BTK) inhibitor] for a period of 4 weeks. These mice underwent serial imaging; we examined the effect of treatment on the areas of meningeal contrast enhancement and noted a significant reduction in the evobrutinib group compared to vehicle (30% reduction versus 5% increase; P = 0.003). We used ultra-high field MRI to identify areas of meningeal inflammation and to track them over time in SJL/J mice with experimental autoimmune encephalomyelitis, and then used this model to identify BTK inhibition as a novel therapeutic approach to target meningeal inflammation. The results of this study provide support for future studies in multiple sclerosis patients with imaging evidence of meningeal inflammation.
Collapse
Affiliation(s)
- Pavan Bhargava
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Sol Kim
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Arthur A Reyes
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | | | | | - Martina Absinta
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Carlos Pardo
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Peter Van Zijl
- F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA
| | - Jiangyang Zhang
- Department of Radiology, New York University, New York, NY, USA
| | - Peter A Calabresi
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
10
|
Noble KG, Houston SM, Brito NH, Bartsch H, Kan E, Kuperman JM, Akshoomoff N, Amaral DG, Bloss CS, Libiger O, Schork NJ, Murray SS, Casey BJ, Chang L, Ernst TM, Frazier JA, Gruen JR, Kennedy DN, Van Zijl P, Mostofsky S, Kaufmann WE, Kenet T, Dale AM, Jernigan TL, Sowell ER. Family income, parental education and brain structure in children and adolescents. Nat Neurosci 2015; 18:773-8. [PMID: 25821911 PMCID: PMC4414816 DOI: 10.1038/nn.3983] [Citation(s) in RCA: 663] [Impact Index Per Article: 73.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2014] [Accepted: 02/27/2015] [Indexed: 01/18/2023]
Abstract
Socioeconomic disparities are associated with differences in cognitive development. The extent to which this translates to disparities in brain structure is unclear. Here, we investigated relationships between socioeconomic factors and brain morphometry, independently of genetic ancestry, among a cohort of 1099 typically developing individuals between 3 and 20 years. Income was logarithmically associated with brain surface area. Specifically, among children from lower income families, small differences in income were associated with relatively large differences in surface area, whereas, among children from higher income families, similar income increments were associated with smaller differences in surface area. These relationships were most prominent in regions supporting language, reading, executive functions and spatial skills; surface area mediated socioeconomic differences in certain neurocognitive abilities. These data indicate that income relates most strongly to brain structure among the most disadvantaged children. Potential implications are discussed.
Collapse
Affiliation(s)
- Kimberly G Noble
- 1] College of Physicians and Surgeons, Columbia University, New York, New York, USA. [2] Teachers College, Columbia University, New York, New York, USA
| | - Suzanne M Houston
- 1] Department of Psychology, University of Southern California, Los Angeles, California, USA. [2] The Saban Research Institute of Children's Hospital, Los Angeles, California, USA. [3] Department of Pediatrics of the Keck School of Medicine, University of Southern California, Los Angeles, California, USA
| | - Natalie H Brito
- Robert Wood Johnson Health and Society Scholar Program, Columbia University, New York, New York, USA
| | - Hauke Bartsch
- Stein Institute for Research on Aging, University of California, San Diego, La Jolla, California, USA
| | - Eric Kan
- 1] The Saban Research Institute of Children's Hospital, Los Angeles, California, USA. [2] Department of Pediatrics of the Keck School of Medicine, University of Southern California, Los Angeles, California, USA
| | - Joshua M Kuperman
- 1] Multimodal Imaging Laboratory, University of California, San Diego, La Jolla, California, USA. [2] Department of Radiology, University of California, San Diego, La Jolla, California, USA. [3] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA
| | - Natacha Akshoomoff
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Center for Human Development, University of California, San Diego, La Jolla, California, USA. [3] Department of Psychiatry, University of California, San Diego, La Jolla, California, USA
| | - David G Amaral
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] The MIND Institute, University of California at Davis, Davis, California, USA
| | - Cinnamon S Bloss
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] The Qualcomm Institute, University of California, San Diego, La Jolla, California, USA
| | | | - Nicholas J Schork
- Human Biology, J. Craig Venter Institute, University of California, San Diego, La Jolla, California, USA
| | - Sarah S Murray
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Pathology, University of California, San Diego, La Jolla, California, USA
| | - B J Casey
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Weill Medical College of Cornell University, New York, New York, USA
| | - Linda Chang
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Medicine, John A. Burns School of Medicine, University of Hawaii and the Queen's Medical Center, Honolulu, Hawaii, USA
| | - Thomas M Ernst
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Medicine, John A. Burns School of Medicine, University of Hawaii and the Queen's Medical Center, Honolulu, Hawaii, USA
| | - Jean A Frazier
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Jeffrey R Gruen
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. [3] Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA. [4] Department of Investigative Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
| | - David N Kennedy
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Peter Van Zijl
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA. [3] Kennedy Krieger Institute, Baltimore, Maryland, USA
| | - Stewart Mostofsky
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Kennedy Krieger Institute, Baltimore, Maryland, USA
| | - Walter E Kaufmann
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA
| | - Tal Kenet
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Department of Neurology, Massachusetts General Hospital, Massachusetts, USA
| | - Anders M Dale
- 1] Multimodal Imaging Laboratory, University of California, San Diego, La Jolla, California, USA. [2] Department of Radiology, University of California, San Diego, La Jolla, California, USA. [3] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [4] Department of Cognitive Science, University of California, San Diego, La Jolla, California, USA. [5] Department of Neurology, Department of Neurosciences, University of California, San Diego, La Jolla, California, USA. [6] Center for Translational Imaging and Personalized Medicine, University of California San Diego, La Jolla, California, USA
| | - Terry L Jernigan
- 1] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA. [2] Center for Human Development, University of California, San Diego, La Jolla, California, USA. [3] Department of Psychiatry, University of California, San Diego, La Jolla, California, USA. [4] Department of Cognitive Science, University of California, San Diego, La Jolla, California, USA
| | - Elizabeth R Sowell
- 1] The Saban Research Institute of Children's Hospital, Los Angeles, California, USA. [2] Department of Pediatrics of the Keck School of Medicine, University of Southern California, Los Angeles, California, USA. [3] The Pediatric Imaging, Neurocognition, and Genetics Study, San Diego, California, USA
| |
Collapse
|